Maternal undernutrition programmes atherosclerosis in the ApoE*3-Leiden mouse.
Poor quality of nutrition during fetal development is associated with adverse health outcomes in adult life. Epidemiological studies suggest that markers of fetal undernutrition are predictive of risk of the metabolic syndrome and CHD. Here we show that feeding a low-protein diet during pregnancy programmed the development of atherosclerosis in ApoE*3-Leiden mice. ApoE*3-Leiden mice carry a mutation of human ApoE*3 rendering them prone to atherosclerosis when fed a diet rich in cholesterol. It was noted that fetal exposure to protein restriction led to a greater degree of dyslipidaemia in mice when fed an atherogenic diet, with low-protein-exposed ApoE*3 mice having elevated total plasma cholesterol (34 % higher; P < 0.001) and TAG (39 % higher; P < 0.001) relative to offspring exposed to a control diet in utero. The low-protein group developed more severe atherosclerotic lesions within the aortic arch (2.61-fold greater lesion area; P < 0.001). Analysis of a targeted gene array suggested a potential role for members of the LDL receptor superfamily, along with similar programmed suppression of the mRNA expression of hepatic sterol regulatory element-binding protein-1c. This indicates that disordered lipid metabolism may play a role in the fetal programming of atherosclerosis in this model. Whereas earlier studies have shown early programming of cardiovascular risk factors, these results demonstrate for the first time that the interaction of prenatal undernutrition with a postnatal atherogenic diet increases the extent of atherosclerotic disease.
Yates
Zoe
Z
School of Biosciences, University of Nottingham, Sutton Bonington, Loughborough LE12 5RD, UK.
Tarling
Elizabeth J
EJ
Langley-Evans
Simon C
SC
Salter
Andrew M
AM
D000818:Animals; D053318:Apolipoprotein E3 / Q000235:genetics; D050197:Atherosclerosis / Q000196:embryology* / Q000503:physiopathology; D002784:Cholesterol / Q000097:blood; D018753:Diet, Protein-Restricted; D004044:Dietary Proteins / Q000008:administration & dosage; D005260:Female; D047109:Fetal Development / Q000502:physiology; D005838:Genotype; D050356:Lipid Metabolism / Q000502:physiology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000503:physiopathology*; D039401:Prenatal Nutritional Physiological Phenomena; D014280:Triglycerides / Q000097:blood
D053318:Apolipoprotein E3; D004044:Dietary Proteins; D014280:Triglycerides; D002784:Cholesterol
Physiol Rev. 2006 Apr;86(2):465-514
16601267
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
12184808
Lancet. 1989 Sep 9;2(8663):577-80
2570282
J Clin Invest. 1997 Dec 1;100(11):2680-90
9389731
Eur Heart J. 2001 Jan;22(1):4-9
11133201
Cell. 1997 May 2;89(3):331-40
9150132
Proc Nutr Soc. 2006 Feb;65(1):97-105
16441949
J Clin Invest. 1998 Feb 1;101(3):689-95
9449704
Circ Res. 2000 Nov 10;87(10):946-52
11073892
Br J Nutr. 2007 Sep;98(3):517-24
17442129
Science. 2004 Sep 17;305(5691):1733-6
15375258
J Clin Invest. 1998 Jun 1;101(11):2331-9
9616204
J Clin Invest. 1991 Aug;88(2):643-55
1864973
Clin Nutr. 1994 Oct;13(5):319-24
16843406
Lancet. 1993 Apr 10;341(8850):938-41
8096277
Am J Physiol Endocrinol Metab. 2007 Jun;292(6):E1702-14
17299084
Circulation. 2002 Mar 19;105(11):1360-7
11901049
Clin Sci (Lond). 1994 Feb;86(2):217-22; discussion 121
8143432
Atherosclerosis. 1987 Dec;68(3):231-40
3426656
Hum Mutat. 1992;1(6):445-66
1301956
J Biol Chem. 1993 May 15;268(14):10540-5
7683682
Int J Obes Relat Metab Disord. 2001 May;25(5):735-40
11360158
J Clin Invest. 1996 Mar 1;97(5):1184-92
8636429
Clin Chem Lab Med. 2005;43(5):470-9
15899668
Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):926-33
8696955
ILAR J. 2006;47(1):5-14
16391426
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11603-7
7903453
Clin Sci (Lond). 1996 Nov;91(5):607-15
8942400